Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-25 @ 1:42 PM
NCT ID:
NCT00391092
Group ID:
EG000
Title:
Trastuzumab + Docetaxel
Description:
Trastuzumab 8 mg/kg loading dose administered intravenously on Day 1 of Cycle 1, followed by docetaxel 100 mg/m\^2 on Day 2 of Cycle 1. Then a maintenance dose of trastuzumab at 6 mg/kg and docetaxel at 100 mg/m\^2 were administered intravenously on Day 1 of each 3-weekly cycle until disease progression, unacceptable toxicity (requiring discontinuation of study treatment), or withdrawal of participant's consent, and for a minimum of 6 cycles, respectively.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
63
Serious Number At Risk:
206
Other Number Affected:
198
Other Number At Risk:
206
Study:
NCT00391092
Results Section:
NCT00391092
Adverse Events Module:
NCT00391092